8 Ensemble Capital Bruker Trades
The first Bruker trade was made in Q1 2013. Since then Ensemble Capital bought shares three more times and sold shares on four occasions. The investor sold all their shares in Q4 2014 and doesn't own any shares in Bruker anymore.
Avg closing price
Price range
Sold -191 Thousand shares
Q4 2014
Avg closing price
$19.25
Price range
$17.90
-
$20.89
Increased shares by 1.0% (+1.84 Thousand shares)
Q3 2014
Avg closing price
$21.42
Price range
$18.52
-
$24.56
Increased shares by 0.3% (+625 shares)
Q2 2014
Avg closing price
$21.70
Price range
$20.03
-
$24.45
Sold 4.6% shares (-9.18 Thousand shares)
Q1 2014
Avg closing price
$21.81
Price range
$19.07
-
$24.25
Sold 3.9% shares (-8.11 Thousand shares)
Q4 2013
Avg closing price
$19.61
Price range
$18.56
-
$21.23
Sold 13.4% shares (-31.9 Thousand shares)
Q3 2013
Avg closing price
$19.07
Price range
$15.91
-
$20.99
Increased shares by 928.2% (+214 Thousand shares)
Q2 2013
Avg closing price
$17.29
Price range
$15.94
-
$19.13
New holding (+23.1 Thousand shares)
Q1 2013
Avg closing price
$17.47
Price range
$15.97
-
$19.10
News about Bruker Corp and Ensemble Capital
Peeling Back The Layers: Exploring Bruker Through Analyst Insights
Throughout the last three months, 4 analysts have evaluated Bruker BRKR, offering a diverse set of opinions from bullish to bearish. Summarizing their recent...
IONpath Closes $18 Million Series B Financing to Advance Precision Medicine
MENLO PARK, Calif., Sept. 24, 2020 /PRNewswire/ -- IONpath, Inc., the leader in high-definition spatial proteomics, today announced the close of a $18 millio...